Janus Henderson Global Life Sciences Fund A2 USD
IE0009355771
Janus Henderson Global Life Sciences Fund A2 USD/ IE0009355771 /
NAV22/05/2024 |
Chg.-0.0500 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
54.2600USD |
-0.09% |
reinvestment |
Equity
Worldwide
|
Janus Henderson Inv. ▶ |
Objectif d'investissement
The Fund seeks long - term growth of capital by investing primarily in life - science equity securities of companies located anywhere in the world and selected for their growth potential.
Opérations
Type de rendement: |
reinvestment |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Health / Pharma |
Benchmark: |
MSCI World Healthcare Index |
Début de l'exercice: |
01/01 |
Dernière distribution: |
- |
Banque dépositaire: |
J.P. Morgan SE, Dublin Branch |
Domicile: |
Ireland |
Permission de distribution: |
Austria, Germany, Switzerland, United Kingdom |
Gestionnaire du fonds: |
Andy Acker, Daniel Lyons |
Actif net: |
4.03 Mrd.
USD
|
Date de lancement: |
31/03/2000 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
5.00% |
Frais d'administration max.: |
1.50% |
Investissement minimum: |
2,500.00 USD |
Deposit fees: |
- |
Frais de rachat: |
0.00% |
Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
Société de fonds: |
Janus Henderson Inv. |
Adresse: |
201 Bishopsgate, EC2M 3AE, London |
Pays: |
United Kingdom |
Internet: |
www.janushenderson.com/
|
Actifs
Stocks |
|
99.76% |
Bonds |
|
0.20% |
Autres |
|
0.04% |
Pays
United States of America |
|
72.71% |
Denmark |
|
7.02% |
United Kingdom |
|
4.39% |
Switzerland |
|
3.42% |
France |
|
2.61% |
Netherlands |
|
1.59% |
Japan |
|
1.49% |
Ireland |
|
1.36% |
Virgin Islands (British) |
|
0.86% |
China |
|
0.76% |
Cayman Islands |
|
0.29% |
Canada |
|
0.20% |
Autres |
|
3.30% |
Branches
Pharma/Biotechnology |
|
61.35% |
Healthcare services |
|
16.96% |
Healthcare appliances |
|
16.54% |
Parma, wholesale |
|
1.65% |
Autres |
|
3.50% |